Balyasny Asset Management’s Bausch Health BHC Stock Holding History

Balyasny Asset Management’s Portfolio BHC Stock Details BHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-1,000,000	Closed	-$8M	–	2265
2023 Q2	$8M	Buy	+1,000,000	New	+$7.37M	0.02%	875
2022 Q3	–	Sell	-375,000	Closed	-$3.13M	–	2853
2022 Q2	$3.13M	Buy	+375,000	New	+$5.24M	0.01%	1156
2022 Q1	–	Sell	-140,000	Closed	-$3.87M	–	2479
2021 Q4	$3.87M	Buy	+140,000	New	+$3.75M	0.01%	940
2020 Q4	–	Sell	-1,100,000	Closed	-$17.1M	–	1331
2020 Q3	$17.1M	Buy	1,100,000 +900,000	+450%	+$15.5M	0.13%	238
2020 Q2	$3.66M	Buy	+200,000	New	+$3.52M	0.03%	595
2018 Q1	–	Sell	-200,000	Closed	-$4.16M	–	1948
2017 Q4	$4.16M	Hold	200,000	–	–	0.01%	917
2017 Q3	$2.87M	Buy	+200,000	New	+$3.02M	0.01%	871
2017 Q1	–	Sell	-109,600	Closed	-$1.59M	–	1585
2016 Q4	$1.59M	Buy	+109,600	New	+$2.01M	0.01%	922
2016 Q2	–	Sell	-825,000	Closed	-$21.7M	–	1163
2016 Q1	$21.7M	Buy	+825,000	New	+$61M	0.13%	233

Other funds holding BHC

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

GAM

Goldentree Asset Management New York $1.69B AUM 10.69% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

MFN Partners Boston, Massachusetts $4.77B AUM 72.29% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

KKRC

Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Balyasny Asset Management's BHC Position: Q1 2026 in Review

Balyasny Asset Management sold out of Bausch Health (BHC) in Q1 2026, closing a stake of 296,903 shares — an estimated $2.06M sold.

Balyasny Asset Management first reported a position in BHC in Q4 2015 and held it in 25 quarters. The position peaked at $22.3M in Q3 2016. 227 funds tracked by Wall St. Rank hold BHC as of Q1 2026.

Balyasny Asset Management reported no remaining Bausch Health position as of Q1 2026 after selling out during the quarter.
Balyasny Asset Management sold 296,903 Bausch Health shares in Q1 2026, an estimated $2.06M.
Balyasny Asset Management first reported a position in Bausch Health in Q4 2015 and held it in 25 quarters.
Balyasny Asset Management's Bausch Health position peaked at $22.3M in Q3 2016.
227 funds tracked by Wall St. Rank held Bausch Health as of Q1 2026.

Based on Balyasny Asset Management's 13F filing for Q1 2026, filed 15 May 2026.